Discover how longitudinal EHR data, genomic insights, and proteomics are shifting healthcare from reactive disease treatment to predictive risk management.

Explore how healthcare leaders can establish robust AI governance, balance human accountability with agentic AI, and prepare the workforce for human-machine partnership.

As AI transitions from micro-tasks to autonomous workflows, the true executive mandate shifts. Discover why the future of healthcare leadership is not about managing software rollouts, but architecting the boundaries where machine autonomy ends and human accountability begins.

Healthcare's future will not be shaped only by scientific breakthroughs, but by organisations capable of implementing them at scale. This article explores why implementation, rather than innovation itself, may become healthcare's next competitive advantage.

As AI transforms the economics of knowledge, healthcare's next competitive advantage may no longer be information itself. It may be the quality of the decisions organisations make with it.

AI is helping healthcare move from reactive treatment to predictive prevention. Discover how predictive analytics, biomarkers and personalised insights could reshape healthy longevity and the future of medicine.

There are no long-term forecasts for life sciences growth across Africa. For a continent undergoing such dramatic demographic and economic transformation, that gap is striking. Professor Richard Barker reports from Accra on what he saw — and why the case for optimism is stronger than it appears.

Healthcare systems are under financial strain — and technology is no longer part of the problem. Professor Richard Barker makes the case for how AI, precision health and longevity science, applied through the 4P framework, could save up to a third of all costs.

Is "healthy life extension" more powerful than "healthspan"? And what does "peakspan" add to the debate? Two leading longevity scientists propose new frameworks — and the language we choose may shape the science, regulation and policy that follows.

Lifespan vs healthspan: which should healthy longevity prioritise? A closer look at how this debate shapes research, clinical trials and public policy.